Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Distinct disease-modifying therapies are associated with different blood immune cell profiles in people with relapsing-remitting multiple sclerosis

Published:2024-04 Issue: Volume:131 Page:111826
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Canto-Gomes João,Boleixa Daniela^ORCID,Teixeira Catarina,Martins da Silva Ana,González-Suárez Inés^ORCID,Cerqueira João,Correia-Neves Margarida,Nobrega Claudia^ORCID

Funder

Fundação para a Ciência e a Tecnologia

ERDF

Publisher

Elsevier BV

Reference44 articles.

1. The Multiple Sclerosis International Federation. Atlas of MS 2020. https://www.msif.org/wp-content/uploads/2020/10/Atlas-3rd-Edition-Epidemiology-report-EN-updated-30-9-20.pdf (accessed 27 March 2023).

2. Multiple sclerosis;Filippi;Nat. Rev. Dis. Primers,2018

3. Update on treatment in multiple sclerosis;Callegari;Presse Med.,2021

4. Treatment of multiple sclerosis: a review;Hauser;Am. J. Med.,2020

5. Diagnosis and treatment of multiple sclerosis: a review;McGinley;J. Am. Med. Assoc.,2021

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stem cell therapies: a new era in the treatment of multiple sclerosis;Frontiers in Neurology;2024-05-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP